Spectrum of brain abnormalities detected on whole body F-18 FDG PET/CT in patients undergoing evaluation for non-CNS malignancies

We present the pattern of metabolic brain abnormalities detected in patients undergoing whole body (WB) F-18 flurodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) examination for non-central nervous system (CNS) malignancies. Knowledge of the PET/CT appearance of various...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Madhavi, Jaimini, Abhinav, D’Souza, Maria M, Sharma, Rajnish, Jain, Jyotika, Garg, Gunjan, Singh, Dinesh, Kumar, Nitin, Mishra, Anil K, Grover, Rajesh K, Mondal, Anupam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Pictorial Essay
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237218/
https://www.ncbi.nlm.nih.gov/pubmed/22174526
http://dx.doi.org/10.4103/0972-3919.90271
Descripción
Sumario:We present the pattern of metabolic brain abnormalities detected in patients undergoing whole body (WB) F-18 flurodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) examination for non-central nervous system (CNS) malignancies. Knowledge of the PET/CT appearance of various intracranial metabolic abnormalities enables correct interpretation of PET scans in oncological patients where differentiation of metastasis from benign intracranial pathologies is important and improves specificity of the PET study. A complete clinical history and correlation with CT and MRI greatly helps in arriving at a correct imaging diagnosis.

Ejemplares similares